Russell G. Katz, M.D.

July 3, 2003

Page 9

 

We look forward to working with your team as we progress through the review of this New Drug Application.  Thank you.

 

Sincerely,

(signature: Mary E. Martinson)

 

Mary E. Martinson

Director

Regulatory Affairs, Psychiatry

 

cc:  Dr. Doris Bates (HFD-120)

 

 

STAMPED: APPEARS THIS WAY ON ORIGINAL

 

 

 

 

Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page